Drug Profile
Research programme: rare genetic vision disorder therapeutics - Biogen
Latest Information Update: 28 Jun 2020
Price :
$50
*
At a glance
- Originator Biogen
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Eye disorders